We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-19.4%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.07B
AUM Growth
-$277M
Cap. Flow
+$203M
Cap. Flow %
9.83%
Top 10 Hldgs %
48.47%
Holding
98
New
23
Increased
27
Reduced
24
Closed
17

Sector Composition

Rank Sector Weight
1 Healthcare 95.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
76
Ascendis Pharma A/S
ASND
$16.7B
$577K 0.03%
31,100
AMPH icon
77
Amphastar Pharmaceuticals
AMPH
$888M
$467K 0.02%
38,905
-33,848
-47% -$399K
NKTR icon
78
Nektar Therapeutics
NKTR
$2.39B
$175K 0.01%
851
-8,291
-91% -$1.59M
IRWD icon
79
Ironwood Pharmaceuticals
IRWD
$626M
$117K 0.01%
12,806
-84,818
-87% -$700K
ALKS icon
80
Alkermes
ALKS
$8.47B
-25,895
Closed -$2.06M
ASRT
81
DELISTED
Assertio
ASRT
-1,553
Closed -$1.69M
CHRS icon
82
Coherus Oncology
CHRS
$222M
-15,940
Closed -$366K
CI icon
83
Cigna
CI
$79.6B
-57,104
Closed -$8.36M
HALO icon
84
Halozyme
HALO
$9.9B
-2,075,796
Closed -$36M
JAZZ icon
85
Jazz Pharmaceuticals
JAZZ
$16.1B
-13,550
Closed -$1.91M
MCK icon
86
McKesson
MCK
$104B
-10,401
Closed -$2.05M
UTHR icon
87
United Therapeutics
UTHR
$26.1B
-195,280
Closed -$30.6M
CMRX
88
DELISTED
Chimerix, Inc.
CMRX
-550,100
Closed -$4.92M
CTLT
89
DELISTED
CATALENT, INC.
CTLT
-61,234
Closed -$1.53M
EGRX
90
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-21,899
Closed -$1.94M
SGEN
91
DELISTED
Seagen Inc. Common Stock
SGEN
-1,275,775
Closed -$57.3M
ENDP
92
DELISTED
Endo International plc
ENDP
-31,062
Closed -$1.9M
CBM
93
DELISTED
Cambrex Corporation
CBM
-25,231
Closed -$1.19M
IPXL
94
DELISTED
Impax Laboratories, Inc.
IPXL
-47,031
Closed -$2.01M
HTWR
95
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
-204,008
Closed -$10.3M

Similar funds

Sectoral Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sectoral Asset Management held 98 positions worth $2.07B, down 12% from $2.35B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sectoral Asset Management deployed $203M of net new capital in Q1 2016, opening 23 new positions and adding to 27 existing holdings. Its largest new stake was Portola Pharmaceuticals, Inc.: 1,593,039 shares worth $32.5M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 97% a quarter earlier.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $31.7M trimmed.

  • Sectoral Asset Management's largest Q1 2016 buy was Portola Pharmaceuticals, Inc.: 1,593,039 shares worth $32.5M.
  • Sectoral Asset Management added most to Neurocrine Biosciences in Q1 2016, an estimated $48.9M increase.
  • Sectoral Asset Management's biggest Q1 2016 reduction was Thermo Fisher Scientific, cutting an estimated $31.7M.
  • Sectoral Asset Management fully exited Seagen Inc. Common Stock in Q1 2016, selling an estimated $57.3M.
  • Sectoral Asset Management's ten largest holdings make up 48% of its $2.07B portfolio in Q1 2016.
  • Sectoral Asset Management opened 23 new positions and closed 17 in Q1 2016.
  • Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $2.07B.

Based on Sectoral Asset Management's 13F filing for Q1 2016, filed 13 May 2016.